Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Henry Saker-Clark

GSK strikes deal to buy US vaccine firm Affinivax

PA Archive

GlaxoSmithKline (GSK) has agreed to buy US vaccine technology firm Affinivax in deal worth up to 3.3 billion dollars (£2.6 billion).

It comes as the UK pharmaceutical business seeks to bolster its vaccine operation as part of a shake-up of its portfolio, including the spin-off of its consumer health business.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.